Department of Physiology, School of Medical Sciences, The University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand.
Department of Anatomy and Medical Imaging, School of Medical Sciences, The University of Auckland, Auckland, New Zealand.
J Neuroinflammation. 2022 Jun 11;19(1):139. doi: 10.1186/s12974-022-02499-7.
Therapeutic hypothermia significantly improves outcomes after moderate-severe hypoxic-ischemic encephalopathy (HIE), but it is partially effective. Although hypothermia is consistently associated with reduced microgliosis, it is still unclear whether it normalizes microglial morphology and phenotype.
Near-term fetal sheep (n = 24) were randomized to sham control, ischemia-normothermia, or ischemia-hypothermia. Brain sections were immunohistochemically labeled to assess neurons, microglia and their interactions with neurons, astrocytes, myelination, and gitter cells (microglia with cytoplasmic lipid granules) 7 days after cerebral ischemia. Lesions were defined as areas with complete loss of cells. RNAscope was used to assess microglial phenotype markers CD86 and CD206.
Ischemia-normothermia was associated with severe loss of neurons and myelin (p < 0.05), with extensive lesions, astrogliosis and microgliosis with a high proportion of gitter cells (p < 0.05). Microglial wrapping of neurons was present in both the ischemia groups. Hypothermia improved neuronal survival, suppressed lesions, gitter cells and gliosis (p < 0.05), and attenuated the reduction of myelin area fraction. The "M1" marker CD86 and "M2" marker CD206 were upregulated after ischemia. Hypothermia partially suppressed CD86 in the cortex only (p < 0.05), but did not affect CD206.
Hypothermia prevented lesions after cerebral ischemia, but only partially suppressed microglial wrapping and M1 marker expression. These data support the hypothesis that persistent upregulation of injurious microglial activity may contribute to partial neuroprotection after hypothermia, and that immunomodulation after rewarming may be an important therapeutic target.
治疗性低温显著改善中重度缺氧缺血性脑病(HIE)后的预后,但疗效有限。尽管低温与小胶质细胞减少一致相关,但尚不清楚其是否能使小胶质细胞形态和表型正常化。
将近胎羊(n=24)随机分为假手术对照、缺血正常体温组和缺血低温组。在脑缺血后 7 天,通过免疫组织化学标记评估神经元、小胶质细胞及其与神经元、星形胶质细胞、髓鞘形成和颗粒细胞(具有细胞质脂质颗粒的小胶质细胞)的相互作用。损伤定义为完全丧失细胞的区域。使用 RNAscope 评估小胶质细胞表型标志物 CD86 和 CD206。
缺血正常体温组与神经元和髓鞘严重丢失(p<0.05)相关,广泛的损伤、星形胶质细胞增生和小胶质细胞增生,伴有大量颗粒细胞(p<0.05)。神经元被小胶质细胞包裹存在于两个缺血组中。低温可改善神经元存活,抑制损伤、颗粒细胞和神经胶质增生(p<0.05),并减轻髓鞘面积分数的减少。“M1”标志物 CD86 和“M2”标志物 CD206 在缺血后上调。低温仅部分抑制皮质中的 CD86(p<0.05),但不影响 CD206。
低温可预防脑缺血后的损伤,但仅部分抑制小胶质细胞包裹和 M1 标志物表达。这些数据支持这样的假设,即持续上调致伤性小胶质细胞活性可能导致低温后部分神经保护,并认为复温后的免疫调节可能是一个重要的治疗靶点。